JWP 2021 annual results​

Our team of dedicated & dependable attorneys are experts in a wide range of practice areas. Whether you’re an individual or a corporation, we have the experience and results-driven mindset that you need on your side.

Transparency,regulation and protecting investors

We support the creation of regulatory regimes that increase financial market transparency, protect investors, and facilitate responsible growth of capital markets, while preserving consumer choice and properly balancing benefits versus implementation costs.​

JWP Investment Institute​ (JII)

JWP Investment Institute (JII) leverages the firm’s expertise and generates proprietary research to provide insights on the global economy, markets, geopolitics and long-term asset allocation – all to help our clients and portfolio managers navigate financial markets.​

People & Money

We believe the BlackRock People & Money report is about discovery, truth and opportunity. As the world changes, so does people’s thinking about money. That’s why we traveled the globe to talk to them about this complicated relationship. This is their story. And the more we listen, the better we can act.

Featured Research

We are constantly monitoring present day events and drawing lessons from history to shape and refine our understanding for how markets and economies work. Explore a collection of our research on topics ranging from China to debt crises. ​

Europe’s assets ​

Record annual and quarterly Asset Management operating revenue and year-end assets under management

JAPAN’S ASSET

Strong results are spurring companies to boost dividend payouts and increase share buybacks amid market weakness, in our view. This adds the kicker of attractive cash yields on top of fair valuations. See the chart. Our estimate of the equity risk premium – our preferred valuation gauge that considers the outlook for both interest rates and earnings – remains supportive across DMs, including Japan. 

A good situation for the market​

The market increase in 2020 thanks to the Covid 19